Edwards Lifesciences Corporation (EW)
Symbol Info
Listed Symbol EW
Name Edwards Lifesciences Corporation
Share Info
Annual Info
Latest Fiscal Dividend Per Share $-
Latest Fiscal Date 2018-12-31
Latest Fiscal Revenue $3,722,800,000
Latest Fiscal EPS $3.38
Price Info
21 Day Moving Average $222.8424
21 Day EMA $223.683690
50 Day Moving Average $220.3068
50 Day EMA $218.459170
200 Day EMA $193.899930
200 Day Moving Average 190.818950
52 Week High $230.19
52 Week Low $136.44
52 Week Change $54.398600
Alpha 0.020111
Beta 0.8095
Standard Deviation 0.085352
R2 0.106086
Periods 60
Share Information
10 Day Average Volume 1,058,975
20 Day Average Volume 1,146,953
30 Day Average Volume 1,095,769
50 Day Average Volume 1,051,234
Outstanding Shares 207,969,219
Float Shares 206,840,147
Percent Float 99.46%
Short Interest 2,190,307
Short Percent Float 1.10%
Short Interest Ratio 2.20
Short Date 2019-09-30
Holders
Institutions 1,787
Institute Holdings Date 2019-09-30
Institute Bought Previous 3 Months 12,770,829
Institute Holdings Percent -
Institute Sold Previous 3 Months 21,712,597
Insider Holdings Date
Insider Bought Previous 3 Months -
Insider Holdings Percent -
Insider Sold Previous 3 Months -
Insiders Shares Owned 1,129,072
Price Change
7 Day Price Change $0.3500061
7 Day Percent Change 0.15%
21 Day Price Change $10.1700130
21 Day Percent Change 4.68%
30 Day Price Change $9.6200100
30 Day Percent Change 4.42%
Month To Date Price Change $7.5500
Month To Date Percent 3.43%
90 Day Price Change $34.380005
90 Day Percent Change 17.81%
Quarter To Date $7.550003
Quarter To Date Percent 3.43%
180 Day Price Change $50.200012
180 Day Percent Change 28.32%
200 Day Price Change $37.460007
200 Day Percent Change 19.72%
Year To Date $74.290010
Year To Date Percent 48.50%
Profile
Description Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of heart disease. Its key products include surgical tissue heart valves, transcatheter valve technologies, surgical clips, catheters and retractors, and monitoring systems used to measure a patient's heart function during surgery.
Details
Issue Type CS
Market Cap $47,304,678,554
Sec Type EQS
Auditor PricewaterhouseCoopers LLP
Total Shares Outstanding 207,969,219
CEO Michael A. Mussallem
Employees 12,800
Last Audit UQ
Classification
CIK 0001099800
Industry Medical Devices
Sector Healthcare
NAICS Surgical Appliance and Supplies Manufacturing(339113)
Info
Address One Edwards Way
Irvine, CA 92614
Website http://www.edwards.com
Facisimile +1 949 250-2525
Telephone +1 949 250-2500
Email investor_relations@edwards.com
Key Ratios
Profitability
EBIT Margin 21.50
EBITDA Margin 23.6
Pre-Tax Profit Margin 29.9
Profit Margin Cont 16.30
Gross Margin 74.90
Profit Margin TOT 16.30
Income Statements
Revenue $3,057,600,000
Revenue Per Share $14.7022
Revenue 3 Years $4.99
Revenue 5 Years $9.53
Valuation Measures
PE Ratio 63.00
Enterprise Value $45,468,510,950
Price To Sales 15.471180
Price To Free Cash 162.300000
PE High Last 5 Years 64.8
Price To Book 12.8
Price To Cash Flow 46.8
PE Low Last 5 Years 16.3
Price To Tangible Book 23.1
Financial Strength
Total Debt To Equity 0.2
Int Coverage 27.4
Current Ratio 3.4
Leverage Ratio 1.5
Quick Ratio 2.2
Long Term Debt To Capital 0.16
Assets
Receivables Turnover 5.6
Invoice Turnover 1.60
Assets Turnover 0.50
Management Effectiveness
Return Assets 12.78
Return On Equity 21.61
Return On Capital 17.00
Dividends
Dividend 3 Years $-
Dividend 5 Years $-
Ex Dividend Date
Dividend Rate $-
Dividend Yield -
Payment Type


Your Recent History
NYSE
EW
Edwards Li..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.